A new mental model for how AI can be leveraged in biopharma
Explore the endless opportunities for AI integration in biopharma in our latest webinar: https://vibebio.com/resources/events/how-ai-analysis-supports-drug-dev/
Explore the endless opportunities for AI integration in biopharma in our latest webinar: https://vibebio.com/resources/events/how-ai-analysis-supports-drug-dev/
Explore the possibilities of AI enabled teams in our latest webinar: https://vibebio.com/resources/events/how-ai-analysis-supports-drug-dev/
In the context of drug development, the average phase 3 duration is approximately 2.5 years. It's clear folks want to make investments in technologies and capabilities that allow for quicker advancements if medicines. Can AI help? Find out in our latest webinar: https://vibebio.com/resources/events/how-ai-analysis-supports-drug-dev/
Many biopharma companies want to add leverage and increase capacity to do more with existing resources. Can AI offer a solution? Find out in our latest webinar: https://vibebio.com/resources/events/how-ai-analysis-supports-drug-dev/
Biopharma is going through quite a substantial change given the market volatility over the past few years pushing for the industry overall to drive for efficiency. Can technology, namely AI help support that? Find out in our latest webinar: https://vibebio.com/resources/events/how-ai-analysis-supports-drug-dev/
Asset evaluation in the biopharma space is highly analog and extremely complex, requiring a myriad of experts and stakeholders at the table before a decision is made. Can AI help make this process faster and less burdensome? Find out in our latest webinar: https://vibebio.com/resources/events/how-ai-analysis-supports-drug-dev/
In this demo, explore how VibeOne accelerates pharmaceutical decision-making. Watch as it analyzes unstructured scientific data, performs risk assessments, and delivers actionable insights, allowing teams to prioritize and evaluate drug development opportunities in record time. Perfect for executives looking to make smarter, faster pipeline strategies!
In this episode, VibeCast host Ray Dogum speaks with Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine, about his journey to starting the company in 2014. Insilico Medicine's mission is to extend healthy productive longevity by transforming drug discovery and development with generative artificial intelligence. Full episode: https://www.youtube.com/watch?v=dgoqXHcgXbM
In this episode, VibeCast host Ray Dogum speaks with Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine, about his journey to starting the company in 2014. Insilico Medicine's mission is to extend healthy productive longevity by transforming drug discovery and development with generative artificial intelligence. Full episode: https://www.youtube.com/watch?v=dgoqXHcgXbM Mentioned…
In this episode, VibeCast host Ray Dogum speaks with Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine, about his journey to starting the company in 2014. Insilico Medicine's mission is to extend healthy productive longevity by transforming drug discovery and development with generative artificial intelligence. Key Moments: 00:00:08 -…
In this episode, Toni Campbell, founder of Kinfolk.VC describes the untapped potential of African fintech startups and how to VCs consider potential investments into early-stage startups. Gain insights into the unique challenges that African entrepreneurs face and how venture capital can help navigate and overcome them. Key moments: 00:00:00 -…
What does it take to found a life sciences software company with your son? Guest Bio: Sandra Shpilberg is the CEO & co-founder of Adnexi, a software platform that helps biopharma identify Key Opinion Leaders (KOL) and Digital Opinion Leaders (DOL) and influential HCPs who can accelerate treatment development and…
In this episode, VibeCast host Ray Dogum speaks with Sandra Shpilberg, Co-founder and CEO of Adnexi, about using AI to develop effective strategies for biopharma key expert and digital opinion leader selection to elevate your product launch. Key moments: 00:00:07 - Introducing Sandra Shpilberg 00:01:45 - Transitioning into Biopharma 00:06:06…
Full episode: https://www.youtube.com/watch?v=RLAHc35yaqA In this episode, VibeCast host Ray Dogum speaks with Roy de Souza, Founder and CEO of BreakBio, about personalized cancer vaccines. Guest Bio: Roy de Souza is solving a big problem of our lifetimes: curing solid cancers. BreakBio uses AI/ML to find 30 targets on a patient’s…
In this episode, VibeCast host Ray Dogum speaks with Roy de Souza, Founder and CEO of BreakBio, about personalized cancer treatments. -------------------------------------------------------------------------------------------- The key moments in this episode are: 00:00:07 - Introduction to Vibecast 00:01:01 - Roy de Souza's Journey into Cancer Care and Biotech 00:04:21 - Exploring Theories of…
In this episode, VibeCast host Ray Dogum speaks with Frank Gleeson, Co-Founder and CEO of Satellos Bioscience, about groundbreaking small molecule therapies for Duchenne muscular dystrophy. -------------------------------------------------------------------------------------------- The key moments in this episode are: 00:00:05 - Introducing Satellos Bioscience 00:03:26 - Stem Cells and Duchenne Muscular Dystrophy 00:09:15 - Potential…
In this episode, VibeCast host Ray Dogum speaks with Dr. Alex Federation, Co-Founder and CEO of Talus Bioscience, about leveraging machine learning to unlock the potential of the undruggable genome for groundbreaking therapies. -------------------------------------------------------------------------------------------- The key moments in this episode are: 00:00:06 - Introduction to Vibecast 00:01:01 - Background and…
In this episode, VibeCast host Ray Dogum speaks with Rahul Chaturvedi, Founder and CEO of Clora, about rethinking biotech's operating model, how AI is revolutionizing biotech innovation, and more. -------------------------------------------------------------------------------------------- The key moments in this episode are: 00:00:06 - Introducing Vibecast 00:02:35 - Biotech 2050 Podcast 00:06:48 - Clora's Vision…
In this episode, VibeCast host Ray Dogum speaks with Max Shapiro, CEO of PeopleConnect and PitchForce, about the questions investors want answered before they will invest and how to build a great startup team. -------------------------------------------------------------------------------------------- The key moments in this episode are: 00:00:06 - Introduction to Vibecast 00:00:47 - Max…
In this episode, VibeCast host Ray Dogum speaks with William Smith, PhD, Senior Fellow of Pioneer Institute, about the 340B Drug Program and its challenges. -------------------------------------------------------------------------------------------- The key moments in this episode are: 00:00:06 - Introduction to Vibecast and Guest Background 00:06:16 - Impact of the Inflation Reduction Act 00:10:19…
In this episode, VibeCast host Ray Dogum speaks with Omid Moghadam, Founder & CEO of Namida Lab, about the remarkable journey and the profound impact Namida Lab is making in diagnosing breast cancer from tears. Omid's insights into leveraging tears as a unique biomarker for cancer detection are truly eye-opening!…
In this episode, VibeCast host Ray Dogum speaks with Bryan Vought, PhD and John McShane from the Boston Epigenics Society about advancing epigenetics and revolutionizing technology in biotech. -------------------------------------------------------------------------------------------- The key moments in this episode are: 00:00:06 - Introduction to Vibecast 00:01:47 - The Genesis of the Boston Epigenetics Society…
In this episode, VibeCast host Ray Dogum speaks with Rafael Rosengarten, PhD, CEO of Genialis, about biomarker discovery and drug development. -------------------------------------------------------------------------------------------- The key moments in this episode are: 00:00:33 - Exploring Raphael's Background and Journey 00:04:50 - Favorite Guest on "Talking Precision Medicine" 00:07:02 - Joining Genialis as a…
In this episode, VibeCast host Ray Dogum speaks with Travis Stiles, PhD, CEO of Novoron Biosciences, about Uncovering Protein Dysregulation in Neurodegenerative Disease. -------------------------------------------------------------------------------------------- The key moments in this episode are: 00:00:00 - Introducing Vibecast 00:01:14 - Career Shift to Neuroscience 00:05:19 - Founding Novoron Biosciences 00:09:07 - Drug Development…